AI智能总结
CONTENTS目錄CORPORATE INFORMATIONCHAIRMAN’S STATEMENTMANAGEMENT DISCUSSION AND ANALYSISBIOGRAPHICAL DETAILS OF DIRECTORS ANDSENIOR MANAGEMENTCORPORATE GOVERNANCE REPORTENVIRONMENTAL, SOCIAL ANDGOVERNANCE REPORTREPORT OF THE DIRECTORSINDEPENDENT AUDITOR’S REPORTCONSOLIDATED STATEMENT OFPROFIT OR LOSSCONSOLIDATED STATEMENT OF PROFIT ORLOSS AND OTHER COMPREHENSIVE INCOMECONSOLIDATED STATEMENT OFFINANCIAL POSITIONCONSOLIDATED STATEMENT OFCHANGES IN EQUITYCONSOLIDATED STATEMENT OF CASH FLOWSNOTES TO THE CONSOLIDATEDFINANCIAL STATEMENTSFIVE-YEAR FINANCIAL SUMMARYOF THE GROUP ANNUAL REPORT 20242公司資料5主席報告10管理層討論與分析29董事及高級管理層之履歷詳情36企業管治報告64環境、社會及管治報告107董事會報告132獨立核數師報告139綜合損益表140綜合損益及其他全面收益表141綜合財務狀況表143綜合權益變動表145綜合現金流量表147綜合財務報表附註256本集團五年財務概要 CORPORATE INFORMATIONEPS Creative Health Technology Group LimitedEPS創健科技集團有限公司BOARD OF DIRECTORSExecutive DirectorsMr. Washikita Kenichiro(Chairman and Chief Executive Officer)(appointed with effect from 8 November 2024)Mr. Miyano TsumoruMr. Narumi Shoichi(appointed with effect from 2 December 2024)Mr. Chiu Chun TakMs. Du Yao(appointed with effect from 2 December 2024)Mr. Liang Fei(appointed with effect from 2 December 2024)Mr. Shimada Tatsuji(resigned with effect from 8 November 2024)Mr. Maezaki Masahiro(resigned with effect from 2 December 2024)Mr. Miyazato Hiroki(resigned with effect from 2 December 2024)Non-executive DirectorsMr. Uematsu Takahiro(appointed with effect from 2 December 2024)Mr. Yan PingMr. Kusaba Takuya(resigned with effect from 2 December 2024)Independent Non-executive DirectorsMr. Chan Cheuk HoMr. Choi Koon MingMr. Saito HironobuMs. Zhang Cuiping(appointed with effect from 2 December 2024)Mr. Taniguchi Yasuhiko(resigned with effect from 10 January 2025)COMPANY SECRETARYMr. Chiu Chun TakAUTHORISED REPRESENTATIVESMr. Miyano TsumoruMr. Chiu Chun TakAUDIT COMMITTEEMr. Chan Cheuk Ho(Chairman)Mr. Choi Koon MingMr. Kusaba Takuya(resigned with effect from 2 December 2024)Mr. Uematsu Takahiro(appointed with effect from 2 December 2024) 董事會執行董事鷲北健一郎先生(主席兼行政總裁)(於二零二四年十一月八日獲委任)宮野積先生鳴海尚一先生(於二零二四年十二月二日獲委任)趙俊德先生杜垚女士(於二零二四年十二月二日獲委任)梁非先生(於二零二四年十二月二日獲委任)島田達二先生(於二零二四年十一月八日辭任)前崎匡弘先生(於二零二四年十二月二日辭任)宮里啟暉先生(於二零二四年十二月二日辭任)非執行董事植松高宏先生(於二零二四年十二月二日獲委任)嚴平先生草場拓也先生(於二零二四年十二月二日辭任)獨立非執行董事陳卓豪先生蔡冠明先生齋藤宏暢先生張翠萍女士(於二零二四年十二月二日獲委任)谷口恭彥先生(於二零二五年一月十日辭任)公司秘書趙俊德先生授權代表宮野積先生趙俊德先生審核委員會陳卓豪先生(主席)蔡冠明先生草場拓也先生(於二零二四年十二月二日辭任)植松高宏先生(於二零二四年十二月二日獲委任) CORPORATE INFORMATIONANNUAL REPORT 2024/20252024/2025 年報薪酬委員會蔡冠明先生(主席)提名委員會蔡冠明先生(主席)(於二零二五年一月十日獲委任)杜垚女士(於二零二五年六月二十七日獲委任)谷口恭彥先生(於二零二五年一月十日辭任)宮野積先生(於二零二五年六月二十七日辭任)天健國際會計師事務所有限公司莊士敦道181號15樓1501-08室註冊辦事處Cricket SquareHutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands總辦事處及香港主要營業地點紅磡民樂街23號駿昇中心17樓A室主要股份過戶登記處Conyers Trust Company (Cayman) LimitedCricket SquareHutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands 宮野積先生陳卓豪先生陳卓豪先生核數師香港灣仔大有大廈香港九龍 REMUNERATION COMMITTEEMr. Choi Koon Ming(Chairman)Mr. Miyano TsumoruMr. Chan Cheuk HoNOMINATION COMMITTEEMr. Choi Koon Ming(Chairman)(appointed with effect from 10 January 2025)Ms. Du Yao(appointed with effect from 27 June 2025)Mr. Chan Cheuk HoMr. Taniguchi Yasuhiko(resigned with effect from 10 January 2025)Mr. Miyano Tsumoru(resigned with effect from 27 June 2025)AUDITORConfucius International CPA LimitedRoom 1501-08, 15/F.Tai Yau Building181 Johnston RoadWanchaiHong KongREGISTERED OFFICECricket SquareHutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman IslandsHEAD OFFICE AND PRINCIPAL PLACE OFBUSINESS IN HONG KONGFlat A, 17/F., Gemstar Tower23 Man Lok Street, Hung HomKowloon, Hong KongPRINCIPAL SHARE REGISTRAR AND TRANSFEROFFICEConyers Trust Company (Cayman) LimitedCricket SquareHutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands CORPORATE INFORMATIONEPS Creative Health Technology Group LimitedEPS創健科技集團有限公司HONG KONG BRANCH SHARE REGISTRAR ANDTRANSFER OFFICETricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt Road, Hong KongLEGAL ADVISERS AS TO HONG KONG LAWCLKW Lawyers LLPPRINCIPAL BANKERSMUFG Bank, Ltd.China Construction Bank (Asia) Corporation LimitedThe Hongkong and Shanghai Banking Corporation LimitedShanghai Commercial Bank LimitedCOMPANY’S WEBSITEwww.eps.hkSTOCK CODE3860 香港股份過戶登記分處卓佳證券登記有限公司香港夏愨道16號遠東金融中心17樓香港法律顧問CLKW Lawyers LLP主要往來銀行三菱日聯銀行中國建設銀行(亞洲)股份有限公司香港上海匯豐銀行有限公司上海商業銀行有限公司公司網站www.eps.hk股份代號3860 CHAIRMAN’S STATEMENTANNUAL REPORT 2024/20252024/2025 年報本人謹代表EPS創健科技集團有限公司(「本公司」)董事(「董事」)會(「董事會」)欣然提呈本公司及其附屬公司(統稱「本集團」)截至二零二五年三月三十一日止年度(「報告期」)之年報 。本公司集團將以「創健」為企業名稱所蘊含的「為人類身心健康做出貢獻」的願望為目標 ,努力成為連接中國 、日本及亞洲地區醫療健康產業 、作為事業發展夥伴的「專業商社」,朝著這一願景穩步前進 。憑藉香港作為亞洲樞紐的優勢 ,我們的業務專注於中國 、日本及亞洲其他地區的貿易 。除了我們最初的服裝ODM業務外 ,我們的核心業務還包括經營與醫療保健相關的各種產品 。我們也透過與中國和日本的新創公司和研究機構合作 ,積極推動產品和業務發展 。近年來 ,我們的經營環境發生了許多重大變化 。這些變化揭示了新的挑戰 ,需要我們制定靈活的中長期策略來應對 。在本報告期間內 ,我們重新評估了未來發展路線圖 ,並啟動了業務組合的轉型-從以往投資驅動型業務與盈利性業務相結合的混合模式 ,轉向專注於盈利性業務 。具體而言 ,在本報告期間內 ,我們轉移了日本投資營運業務和內部研發業務 ,從而將業務資產整合到獲利性業務上 。 致股東:業務回顧 Dear Shareholders,O n b e h a l f o f t h e b o a r d ( t h e “B o a r d” ) o f d i r e c t o r s ( t h e“Director(s